Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

被引：0
|
作者：
Bromberg, Jacoline
Issa, Samar
Bukanina, Katerina
Minnema, Monique C.
Seute, Tatjana
Durian, Marc
Cull, Gavin
Schouten, Harry C.
Stevens, Wendy B.
Zijlstra, Josee
Baars, Johanna W.
Nijland, Marcel
Mason, Kylie
Beeker, Aart
van den Bent, Martin
de Jong, Daphne
Gonzales, Michael Anthony
Doorduijn, Jeanette K.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
582
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized HOVON-Nordic Lymphoma Group Phase III Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 6 - 8
  • [22] Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
    Prakash Ambady
    Rongwei Fu
    Laszlo Szidonya
    David M. Peereboom
    Nancy D. Doolittle
    Edward A. Neuwelt
    Journal of Neuro-Oncology, 2020, 147 : 171 - 176
  • [23] Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma
    Siakantaris, Marina P.
    Argyropoulos, Kimon V.
    Ioannou, Savvas
    Papadopoulou, Vasiliki
    Tzeletas, George
    Tsonis, John
    Dimitrakopoulou, Aglaia
    Yiannopoulou, Konstantina G.
    Pangalis, Gerassimos A.
    Vaiopoulos, George
    NEUROLOGIST, 2015, 19 (02) : 35 - 37
  • [24] Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
    Ambady, Prakash
    Fu, Rongwei
    Szidonya, Laszlo
    Peereboom, David M.
    Doolittle, Nancy D.
    Neuwelt, Edward A.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (01) : 171 - 176
  • [25] Rituximab with high-dose methotrexate in primary central nervous system lymphoma
    Kansara, Roopesh
    Shenkier, Tamara N.
    Connors, Joseph M.
    Sehn, Laurie H.
    Savage, Kerry J.
    Gerrie, Alina S.
    Villa, Diego
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1149 - 1154
  • [26] Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam
    Hoang, G. H. Nguyen
    Nguyen, P. T. B.
    Nguyen, H. T. N.
    Do, K. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Preliminary Results of a Phase II Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma
    Yao, Shuna
    Yao, Zhihua
    Yan, Zheng
    Wang, Haiying
    Chu, Junfeng
    Zhao, Shuang
    Zhao, Xinyang
    Liu, Yanyan
    BLOOD, 2023, 142
  • [28] Primary central nervous system lymphoma: a retrospective study
    Tseng, MY
    Tu, YK
    Shun, CT
    JOURNAL OF CLINICAL NEUROSCIENCE, 1998, 5 (04) : 409 - 412
  • [29] Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiaiton temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results
    Glass, Jon
    Won, Minhee
    Schultz, Christopher J.
    Brat, Daniel
    Bartlett, Nancy
    Suh, John H.
    Fisher, Barbara Jean
    Liepman, Marcia K.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma
    Yi, Jun Ho
    Kim, Seok Jin
    Yang, Deok-Hwan
    Do, Young Rok
    Won, Jong Ho
    Baek, Dongwon
    Shin, Ho Jin
    Kim, Dae Sik
    Kim, Hyo Jung
    Kang, Ka-won
    Bae, Sung Hwa
    Kwon, Ji-Hyun
    Kwon, Jung Hye
    Park, Byeong Bae
    Kim, Won Seog
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1773 - 1781
12345